新赫寶克 Havrix 1440 /720 Junior 去活性 A 型肝炎疫苗 衛署菌疫輸字第 000456 號 定性與定量組成 每劑(1.0 毫升)成人用 Havrix 1440 含有: A 型肝炎病毒(去活化)1,2 1 在人類雙套染色體(MRC-5)細胞中製成 2 吸附於水合氫氧化鋁上 1440 ELISA 單位 0.50 毫克 Al3+ 每劑(0.5 毫升)孩童用 Havrix ...
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 ... Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese encephalitis vaccine IC51 and the hepatitis A vaccine HAV...
This Phase 3 study investigated the immunogenicity and safety of IC51 (JE vaccine) and HAVRIX1440 (hepatitis A vaccine) when administered alone or concomitantly to healthy subjects. The immune response was compared between single and concomitant vaccination in terms of geometric mean titre (GMT) ...
Subjects received a booster dose of Havrix1440 intramuscularly as the third dose. Serology samples for hepatitis A virus antibody titers were taken 4-6 weeks later. Anti-hepatitis A virus antibody titers were measured by an inhibition enzyme-linked immunosorbent assay.#Subjects were 20 healthy ...